Market

The multiple dosing studies are expected to be completed by Q2 2015

The product has recently been introduced under the brand Accofil

Forays into the Rs 800-crore nasal inhaler segment

The company plans to commence shipping of Ashlyna immediately

Cipla has been awarded US $188.95 million of Global Fund ARV tender

Under the agreement Mylan will distribute Sovaldi and Harvoni in India

31 corporates have shown growth more than 10 per cent amongst the top 50

Above 20,000 potential buyers including 1,400 international buyers from 180 countries are anticipated

NuFFooDS Expo will be organised concurrently

Emphasises on the fact that clinical research needs to be built on a quality and ethical framework